The anti-doping laboratory in Stockholm did not know that the sample of the Russian figure skater Kamila Valieva needed to be tested before the start of the Beijing Olympics, the Russian Anti-Doping Agency did not mark the sample as a priority. This was reported on the website of the World Anti-Doping Agency (WADA).

“WADA always expects Anti-Doping Organizations to liaise with laboratories to ensure that analysis is expedited so that results are available before athletes travel to major competitions such as the Olympics. According to information received by WADA, the sample in this case was not marked as a priority by RUSADA when it was received by the anti-doping laboratory in Stockholm. This means that the laboratory did not know that it was necessary to accelerate the study of this sample, ”the report says.

WADA expressed dissatisfaction with the decision on Valieva. The main thing at the Olympics Olympics 2022 WADA also expressed disappointment with the decision of the Court of Arbitration for Sport (CAS) in the case of Valieva.

Valieva at the end of December 2021 passed a positive doping test for trimetazidine. The test results became known after the end of the team figure skating competition at the Olympics, in which the Russian team with Valieva won.

According to RUSADA, the reason for the delay in checking the doping test was cases of coronavirus infection among staff in the laboratory in Stockholm.

On February 8, RUSADA imposed a temporary suspension on the figure skater, but the next day it canceled this decision, and Valieva was able to continue participating in the Beijing Games. The admission of the athlete to the Olympics was challenged by the IOC, the World Anti-Doping Agency (WADA) and the International Skating Union (ISU). The judges of the CAS field panel sided with RUSADA and allowed the athlete to compete in the individual competitions, which will be held on February 15 and 17.

bbabo.Net